Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide
InChiKey: RFZKSQIFOZZIAQ-UHFFFAOYSA-N
a tetrahydropyrimidine broad-spectrum anthelmintic
CTEP Derivative dose dependently increases the drinking time
Epub 2009 Sep 10
Trabectedin - CAS# 114899-77-3 pone 6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamideTrabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug